US 10160760
Compounds useful as inhibitors of ATR kinase
granted A61KA61K31/519A61P
Quick answer
US patent 10160760 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 63
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00, A61P43/00